HER3 inhibition in HNSCC syngeneic model: A unique opportunity to disable mTOR oncogenic signaling in HNSCC bypassing the immunosuppressive effects of mTORi. This evidence concerns the gene ERBB3 and head and neck squamous cell carcinoma.